Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia

Antecedentes: La endocarditis infecciosa se ha asociado con mortalidad intrahospitalaria del 12,5% al 22,2%. Objetivo: Estimar los factores pronósticos asociados a mortalidad intrahospitalaria en los pacientes adultos con diagnóstico de Endocarditis infecciosa del año 2007 al año 2017. Metodología:...

Descripción completa

Detalles Bibliográficos
Autores Principales: Pérez, María Alejandra, Zuluaga, Juan David
Otros Autores: Millán, Henry Augusto
Formato: Tesis de maestría (Master Thesis)
Lenguaje:Español (Spanish)
Publicado: Universidad del Rosario 2019
Materias:
Acceso en línea:http://repository.urosario.edu.co/handle/10336/20040
id ir-10336-20040
recordtype dspace
institution EdocUR - Universidad del Rosario
collection DSpace
language Español (Spanish)
topic Endocarditis
Endocarditis bacteriana
Mortalidad hospitalaria
Pronóstico
Enfermedades
Endocarditis bacteriana
Pronóstico medico
Mortalidad
Endocarditis, Bacterial endocarditis, Hospital mortality, Prognosis
spellingShingle Endocarditis
Endocarditis bacteriana
Mortalidad hospitalaria
Pronóstico
Enfermedades
Endocarditis bacteriana
Pronóstico medico
Mortalidad
Endocarditis, Bacterial endocarditis, Hospital mortality, Prognosis
Pérez, María Alejandra
Zuluaga, Juan David
Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia
description Antecedentes: La endocarditis infecciosa se ha asociado con mortalidad intrahospitalaria del 12,5% al 22,2%. Objetivo: Estimar los factores pronósticos asociados a mortalidad intrahospitalaria en los pacientes adultos con diagnóstico de Endocarditis infecciosa del año 2007 al año 2017. Metodología: Estudio observacional, analítico, tipo casos y controles multicéntrico; considerando casos los pacientes con mortalidad intrahospitalaria y controles los pacientes con endocarditis infecciosa que no fallecieron durante la hospitalización. Resultados: Se incluyeron 308 pacientes. La mortalidad intrahospitalaria fue de 32,7%. Las principales variables pronósticos fueron: Complicación con terapia de reemplazo renal (OR 6,669 IC 3,77 – 12,17, p<0,001), compromiso mitral moderado (OR 3,9 IC 1,02 -17,5 p= 0,057), terapia de reemplazo renal (TRR) previo a hospitalización (OR 3,72 IC 1,89 – 7,51, p<0,001) y embolia a sistema nervioso central (OR 2,6 IC 1,53 – 4,44, p< 0,001); como factores protectores: cirugía durante hospitalización (OR 0,39 IC 0,24 – 0,64, p<0,001) y afectación tricúspide (OR 0,39 IC 0,15 – 0,87, p=0,032). Conclusión: El desarrollo de lesión renal aguda con indicación de TRR es el principal factor de riesgo para mortalidad intrahospitalaria. La identificación de lesión renal aguda así como la limitación de los factores de riesgo propios de la misma puede reducir la mortalidad condicionada por este factor. La realización de cirugía durante hospitalización es el factor de buen pronóstico con mayor impacto en mortalidad; la detección de criterios para intervención quirúrgica debe enfatizarse durante el manejo de esta población.
author2 Millán, Henry Augusto
author_facet Millán, Henry Augusto
Pérez, María Alejandra
Zuluaga, Juan David
format Tesis de maestría (Master Thesis)
author Pérez, María Alejandra
Zuluaga, Juan David
author_sort Pérez, María Alejandra
title Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia
title_short Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia
title_full Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia
title_fullStr Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia
title_full_unstemmed Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia
title_sort mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de colombia
publisher Universidad del Rosario
publishDate 2019
url http://repository.urosario.edu.co/handle/10336/20040
_version_ 1694382447371747328
spelling ir-10336-200402021-03-01T19:22:51Z Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia Pérez, María Alejandra Zuluaga, Juan David Millán, Henry Augusto Dennis Verano, Rodolfo Jose Rincón, Laura Fernanda Rincón, Silvia Susana Ariza Ordoñez, Nicólas Oliveros Acuña, Natalia Castro, Génesis Viviana Cruz, José Uribe, Luis Guillermo Ospina, Leonardo Arias, Gerson Kock, Joshua Endocarditis Endocarditis bacteriana Mortalidad hospitalaria Pronóstico Enfermedades Endocarditis bacteriana Pronóstico medico Mortalidad Endocarditis, Bacterial endocarditis, Hospital mortality, Prognosis Antecedentes: La endocarditis infecciosa se ha asociado con mortalidad intrahospitalaria del 12,5% al 22,2%. Objetivo: Estimar los factores pronósticos asociados a mortalidad intrahospitalaria en los pacientes adultos con diagnóstico de Endocarditis infecciosa del año 2007 al año 2017. Metodología: Estudio observacional, analítico, tipo casos y controles multicéntrico; considerando casos los pacientes con mortalidad intrahospitalaria y controles los pacientes con endocarditis infecciosa que no fallecieron durante la hospitalización. Resultados: Se incluyeron 308 pacientes. La mortalidad intrahospitalaria fue de 32,7%. Las principales variables pronósticos fueron: Complicación con terapia de reemplazo renal (OR 6,669 IC 3,77 – 12,17, p<0,001), compromiso mitral moderado (OR 3,9 IC 1,02 -17,5 p= 0,057), terapia de reemplazo renal (TRR) previo a hospitalización (OR 3,72 IC 1,89 – 7,51, p<0,001) y embolia a sistema nervioso central (OR 2,6 IC 1,53 – 4,44, p< 0,001); como factores protectores: cirugía durante hospitalización (OR 0,39 IC 0,24 – 0,64, p<0,001) y afectación tricúspide (OR 0,39 IC 0,15 – 0,87, p=0,032). Conclusión: El desarrollo de lesión renal aguda con indicación de TRR es el principal factor de riesgo para mortalidad intrahospitalaria. La identificación de lesión renal aguda así como la limitación de los factores de riesgo propios de la misma puede reducir la mortalidad condicionada por este factor. La realización de cirugía durante hospitalización es el factor de buen pronóstico con mayor impacto en mortalidad; la detección de criterios para intervención quirúrgica debe enfatizarse durante el manejo de esta población. Background: Infective endocarditis has been associated with in-hospital mortality from 12.5% to 22.2%. Objective: To estimate the prognostic factors associated with in-hospital mortality in adult patients with a diagnosis of infectious endocarditis from 2007 to 2017. Methodology: Observational, analytical study, type cases and multicentric controls; considering patients with in-hospital mortality and controls patients with infective endocarditis who did not die during hospitalization. Results: 308 patients were included. In-hospital mortality was 32.7%. The main prognostic variables were: Complication with renal replacement therapy (OR 6,669 CI 3.77-12.17, p <0.001), moderate mitral compromise (OR 3.9 CI 1.02 -17.5 p = 0.057), Renal replacement therapy (RRT) prior to hospitalization (OR 3.72 CI 1.89 - 7.51, p <0.001) and central nervous system embolism (OR 2.6 CI 1.53 - 4.44, p < 0.001); as protective factors: surgery during hospitalization (OR 0.39 CI 0.24 - 0.64, p <0.001) and tricuspid involvement (OR 0.39 IC 0.15 - 0.87, p = 0.032). Conclusion: The development of acute renal injury with indication of RRT is the main risk factor for in-hospital mortality. The identification of acute renal injury as well as the limitation of the risk factors of the same can reduce the mortality conditioned by this factor. The performance of surgery during hospitalization is the factor of good prognosis with the greatest impact on mortality; The detection of criteria for surgical intervention should be emphasized during the management of this population. 2019-08-02 17:50:01: Script de automatizacion de embargos. Correo recibido 29 julio 2019 Buena tarde señores Universidad del Rosario. Por medio de la presente los autores del trabajo de grado: Mortalidad intrahospitalaria y factores pronósticos en pacientes con endocarditis infecciosa en 4 hospitales de Colombia solicitamos amablemente que el trabajo que será anexado en la página de la universidad NO tenga vista pública y que sea bloqueado durante 1 año mientras el trabajo es sometido a publicación. La revista aún no ha sido escogida por los autores pero en vista del impacto de la publicación y esperando que sea publicado en una revista categoría Q1 se solicita que el acceso en la página de la universidad sea bloqueado. 2020-08-03 01:01:01: Script de automatizacion de embargos. info:eu-repo/date/embargoEnd/2020-08-02 2019-07-26 2019-08-02T22:40:40Z info:eu-repo/semantics/masterThesis info:eu-repo/semantics/acceptedVersion http://repository.urosario.edu.co/handle/10336/20040 spa info:eu-repo/semantics/openAccess application/pdf Universidad del Rosario Especialización en Medicina Interna Facultad de Medicina instname:Universidad del Rosario reponame:Repositorio Institucional EdocUR Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–6. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler Jr VG, Bayer AS, et al. Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century. JAMA. 2010;169(5):463–73. Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A Systematic Review of Population-Based Studies of Infective Endocarditis. Chest. 2007;132(3):1025–35. Prada G, Ferro S. Endocarditis Infecciosa. In: Chalem F Medicina Interna Fundación Instituto de Reumatología e Inmunología. 1997. p. 1337–45. Echeverría R, Rozo J, Jaramillo C, Rodríguez C. Características epidemiológicas de la endocarditis infecciosa en la Fundación Clínica A. Shaio entre 1994-2001. Rev Col Cardiol. 2002;10:59–63. Sénior JM, Lara F, Restrepo Á. Endocarditis infecciosa: descripción clínico-epidemiológica. Acta Med Colomb. 1995;20(4):169–75. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: Changing epidemiology and predictors of 6-month mortality: A prospective cohort study. Eur Heart J. 2007;28(2):196–203. Cantrell M, Yoshikawa T. Infective endocarditis in the aging patient. Gerontology. 1984;30(5):316–26. Durante-Mangoni E, Bradley SF, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, et al. Current Features of Infective Endocarditis in Elderly Patients. Arch Intern Med. 2008;168(19):2095–103. Castillo FJ, Anguita M, Castillo JC, Ruiz M, Mesa D, Suárez de Lezo J. Changes in Clinical Profile, Epidemiology and Prognosis of Left-sided Native-valve Infective Endocarditis Without Predisposing Heart Conditions. Rev Esp Cardiol (Engl Ed). 2015;68(5):445–8. Lerner P, Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med. 1966;274(4):199–2016. Welton D, Young J, Gentry W, Raizner A, Alexander J, Chahine R, et al. Recurrent infective endocarditis: analysis of predisposing factors and clinical features. Am J Med. 1979;66(6):932–8. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155(15):1641–8 Tuazon C, Sheagren J. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis. 1974;129(6):725–7. Lockhart P, Brennan M, Thornhill M, Michalowicz B, Noll J, Bahrani-Mougeot FSH. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc. 2009;140(10):1238–44. Chen S, Liu C, Chao T, Wang K. Dental Scaling and Risk Reduction in Infective Endocarditis : A Nationwide Population-Based Case-Control Study. Can J Cardiol. 2013;29(4):429–33. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. Circulation. 2007;116(15):1736–54. Gould F, Elliot T, Foweraker J, Perry J, Roberts G, Sandoe J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2006;57(6):1035–42. Griffin M, Wilson W, Edwards W, O’Fallon W, Kurland L. Infective endocarditis. JAMA. 1985;254(9):1199–202. McKinsey D, Ratts T, Bisno A. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987;82(4):681–8. Cherubin C, Neu H. Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med. 1971;51(1):83–9. Michel P, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Hear J. 1995;15(B):2–6. Gersony W, Hayes C, Driscoll D, Keane J. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(2). Habib G, Lancellotti P, Antunes M, Bongiorni M, Casalta J, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). G Ital Cardiol. 2016;17(4):277–319. Nucifora G, Badano LP, Viale P, Gianfagna P, Allocca G, Montanaro D, et al. Infective endocarditis in chronic haemodialysis patients: An increasing clinical challenge. Eur Heart J. 2007;28(19):2307–12. Robinson D, Fowler V, Sexton D. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis. 1997;30(4):521. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, Singh RK, et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis. 2005;41(3):406–9. Tornos M, Permanyer-Miralda G, Olona M. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med. 1992;117(7):567. Martin-Dávila P, Fortún J, Navas E, Cobo J, Jiménez-Mena M, Moya JL, et al. Nosocomial endocarditis in a tertiary hospital: An increasing trend in native valve cases. Chest. 2005;128(2):772–9. Finkelstein R, Sobel J, Nagler A. Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. J Med. 1984;15(3):193. Nahass R, Weinstein M, Bartels J. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis. 1990;162(4):967. Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;369(8):785. Mansur A, Grinberg M, da Luz P, Bellotti G. The complications of infective endocarditis. A reappraisal in the 1980s. Complicat Infect endocarditis. 1992;152(12):2428. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;294(24):3012–21. Sexton D, Spelman D. Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Cardiol Clin. 2003;21(2):273–82. Roth G, Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs R. Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014. JAMA. 2017;317(19):1976. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: Results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31(15):1890–7. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88:53–60. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated Left-Sided Native Valve Endocarditis in Adults: Risk Classification for Mortality. J Am Med Assoc. 2003;289(15):1933–40. Wang A, Athan E, Pappas PA, Fowler VG, Olaison L, Almirante B, et al. Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis. JAMA. 2007;297(12):1354–61. Hase R, Otsuka Y, Yoshida K, Hosokawa N. Profile of infective endocarditis at a tertiary-care hospital in Japan over a 14-year period: Characteristics, outcome and predictors for in-hospital mortality. Int J Infect Dis [Internet]. 2015;33:e62–6. Available from: http://dx.doi.org/10.1016/j.ijid.2015.01.003 Şimşek-Yavuz S, Şensoy A, Kaşikçioğlu H, Çeken S, Deniz D, Yavuz A, et al. Infective endocarditis in Turkey: Aetiology, clinical features, and analysis of risk factors for mortality in 325 cases. Int J Infect Dis. 2015;30:e106–14. Sevilla T, López J, Gómez I, Vilacosta I, Sarriá C, García-Granja PE, et al. Evolution of Prognosis in Left-Sided Infective Endocarditis: A Propensity Score Analysis of 2 Decades. J Am Coll Cardiol [Internet]. 2017;69(1):111–2. Available from: http://myaccess.library.utoronto.ca/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=120336392&site=ehost-live Gelvez-Acebal J, Almendro-Delia M, Ruiz J, De Alarc??n A, Mart??nez-Marcos FJ, Reguera JM, et al. Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: A multicenter cohort study. Mayo Clin Proc [Internet]. 2014;89(10):1397–405. Available from: http://dx.doi.org/10.1016/j.mayocp.2014.06.021 Madrid CA, Jaramillo AN, Roncancio G, Gonzáles JM, Franco L, Rendón JC, et al. Epidemiología de la endocarditis infecciosa en pacientes adultos atendidos en un centro cardiovascular de Colombia, experiencia de 10 años. Rev Esp Cardiol. 2014;67(1):914. Noreña IE. Caracterización clínica, microbiológica y ecocardiográfica de pacientes con Endocarditis infecciosa en la Fundación Cardioinfantil 2002-2012. 2014. Camacho J, Umaña JP, Sandoval NF, Carreño M. Factores asociados a mortalidad en pacientes con endocarditis infecciosa sometidos a cirugía cardíaca. Resúmenes xxv congreso colombiano de cardiología y cirugía cardiovascular, Medellin-Colombia; 2014 Franco Sierra S, Eusse Caro A, Atehortua Trujillo M, Vélez A, Castro H, Vallejo C, et al. Endocarditis infecciosa: Análisis de resultados del manejo quirúrgico temprano. Resúmenes xxiv congreso colombiano de cardiología y cirugía cardiovascular, Cali-Colombia; 2012. Cabell CH, Pond KK, Peterson GE, Durack DT, Corey GR, Anderson DJ, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J. 2001;142(1):75–80. Muñoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, et al. Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine (Baltimore) [Internet]. 2015;94(43):e1816. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84946567058&partnerID=tZOtx3y1 Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M, et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect. 2012;18(12). Thuny F, Disalvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, et al. Risk of embolism and death in infective endocarditis: Prognostic value of echocardiography - A prospective multicenter study. Circulation. 2005;112(1):69–75. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. Vol. 36, European Heart Journal. 2015. 3075–3123 p Anantha Narayanan M, Mahfood Haddad T, Kalil AC, Kanmanthareddy A, Suri RM, Mansour G, et al. Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis. Heart [Internet]. 2016;102(12):950–7. Available from: http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2015-308589 Chu VH, Cabell CH, Benjamin DK, Kuniholm EF, Fowler VG, Engemann J, et al. Early Predictors of In-Hospital Death in Infective Endocarditis. Circulation. 2004;109(14):1745–9. Daniel W, Mügge A, Martin R, Lindert O, Hausmann D, Nonnast-Daniel B, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324(12):795–800. Cosmi JE, Tunick PA, Kronzon I. Mortality in patients with paravalvular abscess diagnosed by transesophageal echocardiography. J Am Soc Echocardiogr. 2004;17(7):766–8. Medina M, Camacho J, Castañeda X, Carreño M. Factores asociados a mortalidad y complicaciones en endocarditis infecciosa de válvula protésica en institución hospitalaria de Colombia. Universidad del Rosario; 2015. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet [Internet]. 2016;387(10021):882–93. Available from: http://dx.doi.org/10.1016/S0140-6736(15)00067-7 McDonald JR. Acute infective endocarditis. Infect Dis Clin North Am. 2009;23(3):643–64. Ben-Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, Siegman-Igra Y. Hospital-acquired infective endocarditis: Should the definition be broadened? Clin Infect Dis. 2004;38(6):843–50. Piper C, Korfer R, Hosrtkotte D. Valve disease: prosthetic valve endocarditis. Heart. 2001;85(5):590–3. Chastre J, Trouillet J. Early infective endocarditis on prosthetic valves. Eur Hear J. 1995;(16 Suppl B):32–8. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32. Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9. Ivan A, Nore E, Mar F, Beltran J. Caracterización clínica , microbiológica y ecocardiográfica de pacientes con Endocarditis infecciosa en la Fundación Cardioinfantil 2002-2012 Caracterización clínica , microbiológica y ecocardiográfica de pacientes con Endocarditis infecciosa en la Fundac. 2012;1–36. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017 Jan;69(3):325–44. Martínez-Sellés M, Muñoz P, Arnáiz A, Moreno M, Gálvez J, Rodríguez-Roda J, et al. Valve surgery in active infective endocarditis: A simple score to predict in-hospital prognosis. Int J Cardiol [Internet]. 2014;175(1):133–7. Available from: http://dx.doi.org/10.1016/j.ijcard.2014.04.266 Chee Q-Z, Tan Y-QB, Ngiam JN, Win MTM, Shen X, Choo J-NJ, et al. The SHARPEN clinical risk score predicts mortality in patients with infective endocarditis: An 11-year study. Int J Cardiol [Internet]. 2015;191:273–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0167527315009705 Park LP, Chu VH, Peterson G, Skoutelis A, Lejko-Zupa T, Bouza E, et al. Validated risk score for predicting 6-month mortality in infective endocarditis. J Am Heart Assoc. 2016;5(4):1–14. Lee SJ, Jeon D, Cho WH, Kim YS. The clinical impacts of apparent embolic event and the predictors of in-hospital mortality in patients with infective endocarditis. J Korean Med Sci. 2014;29(12):1646–50. Monteiro TS, Correia MG, Golebiovski WF, Barbosa GIF, Weksler C, Lamas CC. Asymptomatic and symptomatic embolic events in infective endocarditis: associated factors and clinical impact. Brazilian J Infect Dis [Internet]. 2017;21(3):240–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1413867017301587 Novy E, Sonneville R, Mazighi M, Klein IF, Mariotte E, Mourvillier B, et al. Neurological complications of infective endocarditis: New breakthroughs in diagnosis and management. Med Mal Infect [Internet]. 2013;43(11–12):443–50. Available from: http://dx.doi.org/10.1016/j.medmal.2013.09.010 Diab M, Guenther A, Sponholz C, Lehmann T, Faerber G, Matz A, et al. Pre-operative stroke and neurological disability do not independently affect short- and long-term mortality in infective endocarditis patients. Clin Res Cardiol. 2016 Oct;105(10):847–57. Ilhao Moreira R, Coutinho Cruz M, Moura Branco L, Galrinho A, Coutinho Miranda L, Fragata J, et al. Infective endocarditis: Surgical management and prognostic predictors. Rev Port Cardiol. 2018 May;37(5):387–94. Cecchi E, Ciccone G, Chirillo F, Imazio M, Cecconi M, Del Ponte S, et al. Mortality and timing of surgery in the left-sided infective endocarditis: an Italian multicentre study. Interact Cardiovasc Thorac Surg. 2018 Apr;26(4):602–9. Kang D-H, Kim Y-J, Kim S-H, Sun BJ, Kim D-H, Yun S-C, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012 Jun;366(26):2466–73. Jia L, Wang Z, Fu Q, Bu H, Wei M. Could Early Surgery Get Beneficial in Adult Patients with Active Native Infective Endocarditis? A Meta-Analysis. Biomed Res Int. 2017;2017:3459468. Olmos C, Vilacosta I, Habib G, Maroto L, Fernandez C, Lopez J, et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 2017 Sep;103(18):1435–42. Gatti G, Benussi B, Gripshi F, Della Mattia A, Proclemer A, Cannata A, et al. A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system. Infection. 2017 Aug;45(4):413–23. Varela Barca L, Navas Elorza E, Fernendez-Hidalgo N, Moya Mur JL, Muriel Garcia A, Fernandez-Felix BM, et al. Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis. Infection. 2019 Jun; Díez-Villanueva P, Muñoz P, Marín M, Bermejo J, de Alarcón González A, Fariñas MC, et al. Infective endocarditis: Absence of microbiological diagnosis is an independent predictor of inhospital mortality. Int J Cardiol [Internet]. 2016;220:162–5. Available from: http://dx.doi.org/10.1016/j.ijcard.2016.06.129 van den Brink F, Hasenaar J, Winia V, Klomp M, Van Vlies B, Nicastia D, et al. Prognostic factors in infective endocarditis in general hospitals in the Netherlands. Netherlands Hear J [Internet]. 2016; Available from: http://link.springer.com/10.1007/s12471-016-0846-2 Abdallah L, Remadi JP, Habib G, Salaun E, Casalta JP, Tribouilloy C. Long-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis. Arch Cardiovasc Dis [Internet]. 2016;109(4):260–7. Available from: http://dx.doi.org/10.1016/j.acvd.2015.11.012 Asgeirsson H, Thalme A, Kristjansson M, Weiland O. Incidence and outcome of Staphylococcus aureus endocarditis-a 10-year single-centre northern European experience. Clin Microbiol Infect [Internet]. 2015;21(8):772–8. Available from: http://dx.doi.org/10.1016/j.cmi.2015.04.014 Lauridsen TK, Park L, Tong SYC, Selton-Suty C, Peterson G, Cecchi E, et al. Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis: Analysis From the International Collaboration on Endocarditis-Prospective Echo Cohort Study. Circ Cardiovasc Imaging. 2015 Jul;8(7):e003397. Zencir C, Akpek M, Senol S, Selvi M, Onay S, Cetin M, et al. Association between hematologic parameters and in-hospital mortality in patients with infective endocarditis. Kaohsiung J Med Sci [Internet]. 2015;31(12):632–8. Available from: http://dx.doi.org/10.1016/j.kjms.2015.10.004 Guray Y, Ipek EG, Guray U, Demirkan B, Kafes H, Asarcikli LD, et al. Red cell distribution width predicts mortality in infective endocarditis. Arch Cardiovasc Dis [Internet]. 2014;107(5):299–307. Available from: http://dx.doi.org/10.1016/j.acvd.2014.04.008 Wang TKM, Oh T, Voss J, Pemberton J. Characteristics and outcomes for right heart endocarditis: six-year cohort study. Heart Lung Circ. 2014 Jul;23(7):625–7. Chaudry MS, Carlson N, Gislason GH, Kamper A-L, Rix M, Fowler VGJ, et al. Risk of Infective Endocarditis in Patients with End Stage Renal Disease. Clin J Am Soc Nephrol. 2017 Nov;12(11):1814–22. Ramos-Martinez A, Roque F, Farinas MC, Munoz P, Verde E, Cuerpo GP, et al. Prognostic factors of infective endocarditis in patients on hemodialysis: A case series from a National Multicenter Registry. Int J Cardiol. 2017 Aug;241:295–301. Nadji G, Rusinaru D, Remadi J-P, Jeu A, Sorel C, Tribouilloy C. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009 Jul;11(7):668–75. CDC, NHSN. CDC / NHSN Surveillance Definitions for Specific Types of Infections. Surveill Defin. 2014;2015(January):1–24. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Clasification and Stratification [Internet]. Vol. 39, American Journal of Kidney Diseases. 2002. 1–266 p. Available from: www.kdoqi.org Guía de práctica clínica ( GPC ) basada en la evidencia científica para la atención de la infección por VIH / Sida en adolescentes ( con 13 años de edad o más ) y adultos . 2014. Guide P, Copd TO. Global Initiative for Chronic Obstructive Lung A Guide for Health Care Professionals Global Initiative for Chronic Obstructive Disease. Glob Initiat chronic Obstr lung Dis. 2010;22(4):1–30. The Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing CLSI supplement M100S. Clinical and Laboratory Standards Institute, Wayne, PA. 2016. 256 p. Centers for Diasease Control and Prevention. CDC. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE). Natl Cent Emerg Zoonotic Infect Dis [Internet]. 2015;(November):24. Available from: https://www.osha.gov/SLTC/ebola/control_prevention.html Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11(2):202–19. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Hear J – Cardiovasc Imaging [Internet]. 2016;17(12):1321–60. Available from: https://academic.oup.com/ehjcimaging/article-lookup/doi/10.1093/ehjci/jew082 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129-2200m. Naranjo MV. Hallazgos radiográficos del edema agudo de pulmón. 2014;(609):123–7. Makris K, Spanou L. Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev [Internet]. 2016;37(2):85–98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28303073%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5198510 Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am [Internet]. 2017;101(3):587–606. Available from: http://dx.doi.org/10.1016/j.mcna.2016.12.011 Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA. 2017 Apr;317(16):1652–60. Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665. Damasco P V, Ramos JN, Correal JCD, Potsch M V, Vieira V V, Camello TCF, et al. Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals. Infection. 2014 Oct;42(5):835–42. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VGJ, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar;169(5):463–73. Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol. 1998 Feb;49(2):96–101. Le V, Gill S. Serious complications after infective endocarditis. Dan Med Bull. 2010 Oct;57(10):A4192. Majumdar A, Chowdhary S, Ferreira MA, Hammond LA, Howie AJ, Lipkin GW, et al. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant. 2000 Nov;15(11):1782–7. Gagneux-Brunon A, Pouvaret A, Maillard N, Berthelot P, Lutz MF, Cazorla C, et al. Acute kidney injury in infective endocarditis: A retrospective analysis. Med Mal Infect. 2019 Apr; Lopez J, Sevilla T, Vilacosta I, Garcia H, Sarria C, Pozo E, et al. Clinical significance of congestive heart failure in prosthetic valve endocarditis. A multicenter study with 257 patients. Rev Esp Cardiol (Engl Ed). 2013 May;66(5):384–90. Tavazzi L, Senni M, Metra M, Gorini M, Cacciatore G, Chinaglia A, et al. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail. 2013 May;6(3):473–81. Choi KH, Lee GY, Choi J-O, Jeon E-S, Lee H-Y, Cho H-J, et al. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction. Heart. 2018 Mar;104(6):525–32. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007 Feb;44(3):364–72. Nagy M, Alkady H, Abo Senna W, Abdelhay S. Predictors of surgical outcome in isolated prosthetic mitral valve endocarditis. Asian Cardiovasc Thorac Ann. 2018 Sep;26(7):517–23. Grabowski M, Hryniewiecki T, Janas J, Stepinska J. Clinically overt and silent cerebral embolism in the course of infective endocarditis. J Neurol. 2011 Jun;258(6):1133–9. Lee SJ, Jeon D, Cho WH, Kim YS. The clinical impacts of apparent embolic event and the predictors of in-hospital mortality in patients with infective endocarditis. J Korean Med Sci. 2014 Dec;29(12):1646–50. Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, et al. Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis. 2014 Apr;14:230. Hodges KE, Hussain ST, Stewart WJ, Pettersson GB. Surgical management of infective endocarditis complicated by ischemic stroke. J Card Surg. 2017 Jan;32(1):9–13. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995 Dec;110(6):1745–55. Hubert S, Thuny F, Resseguier N, Giorgi R, Tribouilloy C, Le Dolley Y, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol. 2013 Oct;62(15):1384–92. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta J-P, Riberi A, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011 Aug;32(16):2027–33. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011 Nov;306(20):2239–47. Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):336–45. Kang D-H. Timing of surgery in infective endocarditis. Heart. 2015 Nov;101(22):1786–91. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013 Sep;173(16):1495–504. Mistiaen WP. What are the main predictors of in-hospital mortality in patients with infective endocarditis: a review. Scand Cardiovasc J. 2018 Apr;52(2):58–68.
score 12,131701